Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
AIRO: Undervalued Optionality in a Misread Defense Growth Story
Long trade idea - clean balance sheet, attractive gross margins, catalytic market backdrop; trade the re-rating as execution improves
AIRO Group (AIRO) is a recently listed aerospace and autonomy platform whose equity appears discounted by the market because investors focused on head...
F&G (FG) - Technical Weakness, Strong Balance Sheet: A Tactical Long with Defined Risk
Insurance cash flows and a below-book equity price make FG a high-conviction, tactical buy while technical pressure persists.
F&G Annuities & Life (FG) has been sold off through late 2025 into early 2026, but the company’s insurance economics - large asset base (~$96.1B), r...
JPMorgan After Q4 - Cheap Relative to Earnings, But Watch Credit & Rates
Q4 beat on EPS, missed revenue; valuation looks attractive near $308, but policy and macro risks can reprice the stock quickly.
JPMorgan's Q4 print (01/13/2026) showed an EPS beat (5.23 vs 5.05 est.) but slightly softer revenue (45.80B vs 46.66B est.). At ~ $308.6 the shares tr...
Buy Salesforce on Agentforce Acceleration — Normalize FCF to Support a 14x Multiple
Market cap ~ $229B, revenue momentum and AI agent tailwinds argue for a re-rating; trade plan included.
Salesforce is trading at roughly $238.48 (last trade) and a market cap near $229B. Recent top-line strength (Q2 revenue $10.236B) plus accelerating in...
3D Systems: A Tightening Cash Curve — Breakeven Could Trigger a Quick Rerate
Operational cash flow turning the corner — a low multiple, improving OCF and modest revenue base make a tactical long worth considering
3D Systems (DDD) is trading at multi-year low multiples despite sequential improvements in operating cash flow. With operating cash outflows shrinking...
CRISPR Therapeutics - Patience Pays: Buy the Pullback, Trade the Catalysts
A high-risk, event-driven long with clear entry, stops and layered targets through 2026
CRSP is a volatile, binary biotech that now carries early commercial promise via a partnered product and a deep pipeline. Balance-sheet strength reduc...
Dell Is Pricing In Memory Pain; Buy the Pullback for a Recovery Into AI Server Demand
Strong cash flow and an underappreciated AI/data-center runway offset near-term memory-cost headwinds — tactical long with clear entries and stops.
Dell's enterprise hardware franchise is producing steady operating cash and margins even as memory costs create headline risk. With Q2 FY2026 revenue ...
CNQ: High-Yield, Capital-Light Energy Pick for 2026 — 9 Reasons to Own
Canadian Natural Resources as a top energy trade for 2026 — dividend momentum, wide asset mix, and deep value versus recent range.
Canadian Natural Resources (CNQ) is my top energy idea for 2026. The case rests on a resilient production base (heavy crude + bitumen + conventional g...
Datadog Is a Strong Buy Again: Profitability Turning, Cash Flow Solid, AI Tailwinds Intact
Sequential revenue and margin improvement make DDOG an actionable long with defined stops and asymmetric upside.
Datadog's latest quarter (ended 09/30/2025) showed steady top-line growth, ~80% gross margins, positive net income and robust operating cash flow. The...
ADMA Biologics: Why I’m Buying the Dip and My $26 Price Target
Plasma-derived margins are real, the balance sheet is stronger than headlines suggest, but legal and audit risk keep this a tactical, not a no-brainer, trade
ADMA Biologics (ADMA) is a commercial plasma biologics manufacturer showing expanding revenue, durable gross margins and positive operating cash flow....
MPLX: High Yield, Visible Distribution Growth, and a Reason to Buy on Pullbacks
Underappreciated cash flow + steady distribution hikes make MPLX an asymmetric income-growth trade for position investors
MPLX offers a compelling mix of an elevated yield (roughly 7% at current levels), visible distribution increases through 2025, and stable midstream ca...
Short Palantir Now: Don’t Get Caught in the AI Re-rate
AI rotation is real — Palantir looks richly priced for perfection. Short with tight risk control.
Palantir is profitable and cash-generative, but the stock is priced for flawless execution and continued multiple expansion. With the market rotating ...